The CD40-CD40 ligand system: a potential therapeutic target in atherosclerosis

Related Experiment Video

Updated: Oct 4, 2026

Murine Model of CD40-activation of B cells
12:24

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

R P Phipps1, L Koumas, E Leung

  • 1University of Rochester School of Medicine and Dentistry, Department of Microbiology and Immunology, Cancer Center, Rochester NY 14642, USA. Richard_Phipps@urmc.rochester.edu

Current Opinion in Investigational Drugs (London, England : 2000)
|September 27, 2001
PubMed

Insights

Emerging evidence links atherosclerosis, a major cardiovascular disease, to the CD40-CD40 ligand (CD154) pathway. Targeting this immune pathway shows promise for preventing and reversing atherosclerosis progression.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Medical Research

Background:

  • Atherosclerosis is a primary cause of cardiovascular disease globally.
  • Recent research connects atherosclerosis to chronic inflammation and the immune system.
  • The CD40-CD40 ligand (CD154) pathway is implicated in this immune response.

Purpose of the Study:

  • To review emerging evidence on the role of the CD40-CD40 ligand (CD154) pathway in atherosclerosis.
  • To explore the CD40-CD40 ligand pathway as a potential therapeutic target for cardiovascular disease.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of CD40 and CD154 expression in human atherosclerotic plaques.
  • Examination of data from animal models investigating CD40-CD154 pathway disruption.

Main Results:

  • CD40 and CD154 are highly expressed in human atherosclerotic lesions.
  • Disrupting the CD40-CD154 pathway in preclinical models inhibited atherosclerosis progression.
  • Evidence suggests this pathway disruption may even reverse existing atherosclerotic lesions.

Conclusions:

  • The CD40-CD40 ligand (CD154) pathway is a significant factor in atherosclerosis development and progression.
  • Targeting this pathway offers a novel therapeutic strategy for cardiovascular disease.
  • Blockade of CD40-CD154 may be valuable in treating atherosclerosis.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...